Palliative Care Consult Can Cut Hospital Costs in Seriously Ill

Share this content:
Palliative Care Consult Can Cut Hospital Costs in Seriously Ill
Palliative Care Consult Can Cut Hospital Costs in Seriously Ill

WEDNESDAY, May 2, 2018 (HealthDay News) -- For hospitalized adults with serious illness, receiving a palliative care consultation (PCC) is associated with a reduction in hospital costs, according to a review published online April 30 in JAMA Internal Medicine.

Peter May, Ph.D., from Trinity College Dublin, and colleagues conducted a systematic literature review to examine the correlation of a PCC with direct hospital costs among adults with serious illness (cancer; heart, liver, or kidney failure; chronic obstructive pulmonary disease; AIDS/HIV; or selected neurodegenerative conditions). Eight eligible studies were identified; six provided sufficient information for inclusion.

The studies included 133,118 patients, of whom 93.2 percent were discharged alive; 3.6 percent received a PCC. The researchers found that among the studies, the mean Elixhauser index scores for comorbidity varied from 2.2 to 3.5. A statistically significant reduction in costs was seen when patients were pooled, irrespective of diagnosis (−$3,237). In the stratified analyses, a reduction in costs for the cancer and non-cancer subsamples was seen (−$4,251 and −$2,105, respectively). Those with four or more comorbidities versus those with two or fewer had a greater reduction in cost.

"Increasing palliative care capacity to meet national guidelines may reduce costs for hospitalized adults with serious and complex illnesses," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths